Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein

Vaccine

Volumn 24, Issue 11, 2006, Pages 1744-1748

  Mochizuki, Masami ^a  

^a Kyoritsu Seiyaku Corporation   (Japan)

Author keywords

Canine viruses; MDCK cell; Serum free medium

Indexed keywords

ANTIBIOTIC AGENT; GLUTAMINE; PEPTONE; RPMI 1640; SOYBEAN PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANINE ADENOVIRUS TYPE 1; CANINE ADENOVIRUS TYPE 2; CANINE DISTEMPER MORBILLIVIRUS; CANINE PARAINFLUENZA VIRUS; CANINE PARVOVIRUS TYPE 2; COMPARATIVE STUDY; CONCENTRATION PROCESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; CULTURE MEDIUM; NONHUMAN; PARAINFLUENZA VIRUS; PARVOVIRUS; PRIORITY JOURNAL; QUALITY CONTROL; VIROGENESIS; VIRUS CULTURE;

ADENOVIRUSES, CANINE; ANIMALS; CELL LINE; CULTURE MEDIA, SERUM-FREE; DISTEMPER VIRUS, CANINE; DOGS; PARAMYXOVIRINAE; PARVOVIRUS, CANINE; VIRUS CULTIVATION;

EID: 32544459880     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.114     Document Type: Article

References (17)

1. Greene CE, Schultz RD, Ford RB. Canine vaccination. In: Ford RB, guest editor. Vaccines and vaccinations. The veterinary clinics of North America. Philadelphia: W.B. Saunders Co.; 2001. p. 473-92.
2. Merten O-W. Development of serum-free media for cell growth and production of viruses/viral vaccines - Safety issues of animal products used in serum-free media. In: Brown F, Hendriksen C, Sesardic D, Cussler K, editors. Advancing science and elimination of the use of laboratory animals for development and control of vaccines and hormones. Dev Biol Basel, Karger, 2002;111:233-57.
3. R.H. Johnson, G. Siegl, and M. Gautschi Characteristics of feline panleukopaenia virus strains enabling definitive classification as parvoviruses Arch Virusforsch 46 1974 315 324
4. F. Seki, N. Ono, R. Yamaguchi, and Y. Yanagi Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells J Virol 77 2003 9943 9950
5. Kessler N, Thomas-Roche G, Gerentes L, Aymard M. Suitability of MDCK cells grown in a serum-free medium for influenza virus production. In: Brown F, Robertson JS, Schild GC, Wood JM, editors. Inactivated influenza vaccines prepared in cell culture. Dev Biol Stand Basel, Karger, 1999;98:13-21.
6. Merten O-W, Manuguerra J-C, Hannoun C, van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. In: Brown F, Robertson JS, Schild GC, Wood JM, editors. Inactivated influenza vaccines prepared in cell culture. Dev Biol Stand Basel, Karger, 1999;98:23-37.
7. J.T.M. Voeten, R. Brands, A.M. Palache, G.J.M. van Scharrenburg, G.F. Rimmelzwaan, and A.D.M.E. Osterhaus Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium Vaccine 17 1999 1942 1950
8. O.-W. Merten, J.V. Kierulff, N. Castignolles, and P. Perrin Evaluation of the new serum-free medium (MDSS2) for the production of different biologiclas: Use of various cell lines Cytotechnology 14 1994 47 59
9. H. Kallel, P. Perrin, and O.-W. Merten Evaluation of the new medium (MDSS2N), free of serum and animal proteins, for the production of biologicals O.-W. Merten P. Perrin B. Griffiths New developments and new applications in animal cell technology 1998 Kluwer Academic Press Dordrecht 561 568
10. O.-W. Merten, H. Kallel, J.-C. Manuguerra, M. Tardy-Panit, R. Crainic, and F. Delpeyroux The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses Cytotechnology 30 1999 191 201
11. W. Noe, P. Schorn, R. Bux, and W. Berthold Fed-batch strategies for mammalian cell cultures R.E. Spier J.B. Griffiths W. Berthold Animal cell technology: products of today, prospects for tomorrow 1994 Butterworth-Heinemann Oxford 413 418
12. M. Mochizuki, M. Hashimoto, T. Hajima, M. Takiguchi, A. Hashimoto, and Y. Une Virologic and serologic identification of minute virus of canines (canine parvovirus type 1) from dogs in Japan J Clin Microbiol 40 2002 3993 3998
13. P. Perrin, S. Madhusudana, C. Gontier-Jallet, S. Petres, N. Tordo, and O.-W. Merten An experimental rabies vaccine produced with a new BHK-21 susupension cell culture process: use of serum-free medium and perfusion-reactor system Vaccine 13 1995 1244 1250
14. O.-W. Merten, R. Wu, E. Couve, and R. Crainic Evaluation of the serum-free medium MDSS2 for the production of poliovirus on Vero cells in bioreactors Cytotechnology 25 1997 35 44
15. K.I. Berns Parvovirus replication Microbiol Rev 54 1990 316 329
16. B. Makoschey, J.R. Patel, and P.T.J.A. van Gelder Serum-free produced bovine herpesvirus type 1 and bovine parainfluenza type 3 virus vaccines are efficacious and safe Cytotechnology 39 2002 139 145
17. N.M. Frazatti-Gallina, R.M. Mourao-Funches, R.L. Paoli, M.L.N. Silva, C. Miyaki, and Valentini HJG Vero-cell rabies vaccine produced using serum-free medium Vaccine 23 2004 511 517